Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

REGENXBIO Inc. - Common Stock (NQ:RGNX)

9.060 -0.110 (-1.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 476,348
Open 9.190
Bid (Size) 7.820 (3)
Ask (Size) 9.450 (2)
Prev. Close 9.170
Today's Range 8.825 - 9.270
52wk Range 5.035 - 15.36
Shares Outstanding 43,466,186
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Glimpse Into The Expert Outlook On Regenxbio Through 8 Analysts
Via Benzinga
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings
Via Benzinga

Performance

YTD
+15.3%
+15.3%
1 Month
-4.9%
-4.9%
3 Month
+53.3%
+53.3%
6 Month
+9.3%
+9.3%
1 Year
-14.4%
-14.4%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer
Via Benzinga
Dow Dips Over 100 Points; US Jobless Claims Increase
Via Benzinga
Topics Stocks
Earnings Scheduled For May 12, 2025
Via Benzinga
What to Expect from Regenxbio's Earnings
Via Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 7 Analysts
Via Benzinga
Regenxbio Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
The One-Minute Market Report - Saturday, April 26
Via Talk Markets
Topics ETFs Stocks / Equities
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
Via Investor's Business Daily
Topics Government
Where Regenxbio Stands With Analysts
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
Via Benzinga
Signet Jewelers, BGM Group, StoneCo, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday
Via Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 5 Analysts
Via Benzinga
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Workday, Apollo Global To Join S&P 500 Index In Quarterly Balance
Via Investor's Business Daily
Topics Stocks

Frequently Asked Questions

Is REGENXBIO Inc. - Common Stock publicly traded?
Yes, REGENXBIO Inc. - Common Stock is publicly traded.
What exchange does REGENXBIO Inc. - Common Stock trade on?
REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for REGENXBIO Inc. - Common Stock?
The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market
What is the current price of REGENXBIO Inc. - Common Stock?
The current price of REGENXBIO Inc. - Common Stock is 9.060
When was REGENXBIO Inc. - Common Stock last traded?
The last trade of REGENXBIO Inc. - Common Stock was at 07/10/25 04:00 PM ET
What is the market capitalization of REGENXBIO Inc. - Common Stock?
The market capitalization of REGENXBIO Inc. - Common Stock is 393.80M
How many shares of REGENXBIO Inc. - Common Stock are outstanding?
REGENXBIO Inc. - Common Stock has 394M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.